Naoko Nakatani, Akihiro Tamura, Hiroaki Hanafusa, Nanako Nino, Nobuyuki Yamamoto, Hiroyuki Awano, Yasuhiro Tanaka, Naoya Morisada, Suguru Uemura, Atsuro Saito, et al. A novel NFKB1 variant in a Japanese pedigree with common variable immunodeficiency. Human Genome Variation. 2024
Katsuyuki Nishi, Taro Sakamaki, Akiomi Nagasaka, Kevin S. Kao, Kay Sadaoka, Masahide Asano, Nobuyuki Yamamoto, Akifumi Takaori-Kondo, Masanori Miyanishi. Alteration of long and short-term hematopoietic stem cell ratio causes myeloid-biased hematopoiesis. 2024
内原 嘉仁, 梅田 雄嗣, 赤澤 嶺, 窪田 博仁, 才田 聡, 加藤 格, 平松 英文, 山田 洋介, 荒川 歩, 山本 暢之, et al. MGMTタンパク発現は骨肉腫に対するテモゾロミド併用化学療法の治療効果予測に有用なバイオマーカーとなりうる(MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy against osteosarcoma). 日本小児科学会雑誌. 2024. 128. 2. 238-238
Shotaro Inoue, Kaung Htet Nay Win, Cho Yee Mon, Tomoko Fujikawa, Sayaka Hyodo, Suguru Uemura, Toshiaki Ishida, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, et al. Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high-risk neuroblastoma: A case report. Oncology letters. 2023. 26. 3. 369-369